Background Treatment for patients with locally recurrent soft tissue sarcomas after wide resection is challenging, and few studies have examined the results of treating these patients. In treatment of recurrent tumors, it has been reported that positive margins are correlated to local rerecurrence, but the relationship between surgical margin and survival remains controversial and risk factors for local recurrences after wide resection of soft tissue sarcomas are not well established. This study examined clinical outcomes and factors associated with survival and local rerecurrence in patients with local recurrence after initial surgical treatment who underwent another resection with a goal of negative margins. Questions/purposes The purpose of this study was to determine (1) oncologic outcomes (survival rates and local rerecurrence-free rates) of surgical treatment for patients with local recurrence after wide resection; (2) whether factors associated with survival and local rerecurrence-free rates can be determined; and (3) the proportion of patients treated by amputation at final followup. Methods Between 1992 and 2013, we treated 530 patients with soft tissue sarcoma without metastasis. Of those, 26 (5%) were lost before 3 years of followup but were not known to have died. Of the remainder, 59 have had a local recurrence. Of those with a local recurrence, 34 (58%) were treated with wide resection, whereas 25 (42%) were treated with nonsurgical treatment including chemotherapy and radiotherapy. During that period, our general indications for wide resection were patients (1) without distant metastasis; or (2) without distant lymph node metastasis, and contraindications were distant organ metastasis and/or distant lymph node metastasis. Of those treated with wide resection, 30 (88%) were available for followup. We conducted a retrospective analysis of these 30 patients with local recurrence (17 men, 13 women) who had previously undergone wide resection. Patient followup ranged from 1 to 12 years (median, 5 years). Survivorship (including overall survival and survival free from repeat recurrence) was ascertained by the Kaplan-Meier method. Factors associated with survival were evaluated by the log-rank test. Amputations were performed when limb-sparing surgery was deemed unsuitable because of extensive involvement of the limb by tumor, including invasion of multiple muscle compartments and neurovascular components. Survivorship free from amputation was ascertained by the Kaplan-Meier method.
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Results Overall 5-and 10-year Kaplan-Meier survival rates after resection were 70% (95% confidence interval [CI], 50%-91%) and 44% (95% CI, 12%-76%), respectively, and 12 patients (40%) developed distant metastases after the second operation. Ten patients (33%) had additional local recurrences, and overall 5-and 10-year local rerecurrence-free rates were 66% (95% CI, 48%-85%) and 50% (95% CI, 18%-81%), respectively. A positive margin was associated with further recurrence (5-year local rerecurrence-free rates of positive margin: 20% [95% CI, 0%-52%], negative margin: 89% [95% CI, 74%-100%], p < 0.01) and with survival (5-year survival rates of positive margin: 36% [95% CI, 0%-75%], negative margin: 91% [95% CI, 74%-100%], p < 0.01). The survival rate was lower in patients with recurrence developing after 2 years (5-year survival rates of within 2 years: 46% [95% CI, 2%-90%], after 2 years: 83% [95% CI, 62%-100%], p = 0.01). The overall 5-and 10-year amputation-free rates were 86% (95% CI, 74%-99%) and 81% (95% CI, 67%-96%), respectively. Conclusions A surgical procedure with negative margins appears to be important for reducing the likelihood of local recurrences and improving survival of patients with rerecurrence after wide resection of soft tissue sarcomas. Although these findings need to be confirmed in larger studies, it appears that when tumor recurrence is evident within 2 years from the primary surgery, it is associated with a poor prognosis. Local recurrence within 2 years after wide resection may also be an indicator of aggressive tumor biology. Level of Evidence Level IV, therapeutic study.
Introduction
Soft tissue sarcomas are often locally aggressive, and local recurrence rates are reportedly 80% to 90% when simple resection is performed with inadequate or positive margins [12, 18] . However, with sophisticated imaging modalities, adjuvant radiotherapy, and appropriate limb salvage techniques, postoperative local recurrence rates of soft tissue sarcomas have improved to 7% to 15% [4, 7, 16, 20, 25] . Surgical margin, size, grade, tumor histology, location, and the presence or absence of adjuvant therapy are known risk factors for local recurrence, and surgical margin is also an important prognostic factor [2, 9, 18, 19, 26] . We have previously reported that surgical margin and tumor location are risk factors for local recurrence in patients with soft tissue sarcomas and that patients with local recurrence have poor prognoses [22] . Moreover, patients with local recurrences are reportedly predisposed to future recurrences [3, 9, 11, 20, 21, [23] [24] [25] , which are difficult to treat, and have higher amputation rates during surgical resection than those with primary tumors [4, 24] .
Treatment of locally recurrent tumors is further complicated by prior treatment [16, 17, 19, 23] , and in particular, treatment of recurrent tumors after wide resection defined in Enneking's surgical staging system [6] is challenging. Few studies have examined treatment plans for patients with local recurrence after wide resection [1, 11, 21] , and the best management strategy remains unclear. In treatment of recurrent tumors, it has been reported that positive margins are correlated to local recurrence, but the relationship between surgical margin and survival remains controversial [2, 10, 18, 24] , and risk factors for local recurrences after wide resection of soft tissue sarcomas have not been fully established [1, 11, 21] . We thus focused on clinical outcomes of surgical treatment for patients with local recurrence after wide resection and examined factors associated with survival and local rerecurrence.
We therefore sought to determine (1) oncologic outcomes (survival rates and local rerecurrence-free rates) of surgical treatment for patients with local recurrence after wide resection surgery; (2) whether factors associated with survival and local rerecurrence-free rates can be determined; and (3) the proportion of patients treated by amputation for local recurrence at final followup.
Patients and Methods
A retrospective review of our longitudinally maintained database identified 530 patients with malignant soft tissue tumors who underwent wide surgical procedures between 1988 and 2008 at the authors' institutions. Of those, 26 (5%) were lost before 3 years of followup but were not known to have died. Of the remainder, 59 have had a local recurrence. Of those with a local recurrence, 34 (58%) were treated with wide resection, whereas 25 (42%) were treated with nonsurgical treatment including chemotherapy and radiotherapy. During that period, our general indications for wide resection were for patients (1) without distant organ metastasis; or (2) without distant lymph node metastasis. We viewed in patients with distant organ metastasis and/or distant lymph node metastasis resections that were contraindicated. Of those treated with wide resection, 30 (88%) were available for followup. Ultimately, the present study examined 30 patients (mean age, 61 years; range, 9-91 years; 17 men, 13 women) with malignant soft tissue tumors who underwent surgical procedures for local recurrence after wide resection between 1992 and 2013. At initial wide resection, adjuvant chemotherapy was performed in six patients and radiotherapy was performed in four patients. The median time from previous surgery to recurrence was 3.1 6 3.0 years (range, 4 months to 12 years). Median followup was 4.6 6 3.1 years (range, 1-12 years) after the surgical procedure to address the local recurrence. The mean size of recurrent tumors was 7 6 4 cm (range, 2-15 cm). Tumor types included liposarcoma (eight patients), undifferentiated pleomorphic sarcoma (seven patients), myxofibrosarcoma (four patients), leiomyosarcoma (four patients), synovial sarcoma (three patients), fibrosarcoma (two patients), and rhabdomyosarcoma and malignant peripheral nerve sheath tumor (one patient each). Tumors were located in the thigh (12 patients), forearm (four patients), the buttock and abdominal wall (three patients each), and the anterior chest, back, low back, inguinal, upper arm, calf, neck, and hand (one patient each). Twenty-seven recurrent tumors were found deep within muscles, whereas only three tumors were found in subcutaneous tissue (Table 1) . Our surgical approaches have been described earlier [22] ; here we summarize our surgical methods briefly. We preoperatively evaluated locally recurrent soft tissue sarcomas with CT and MRI to prepare for the surgical procedures. Surgical scars and tumors in subcutaneous tissue were analyzed by enhanced CT and T1-weighted MRI scans, and tumors in muscle were assessed by T2-weighted MRI scans. Tumors were removed along with surgical scars from previous operations and surrounding tissue. For soft tissue defects, 14 patients received a musculocutaneous flap and three patients received a free skin graft. In three patients, bony defects were created at the time of the operation for recurrence because of bony involvement by tumor. For these bony defects, one patient received bone autografts and two patients received prosthetics. In five patients, blood vessels adherent or surrounded by tumor were removed with the tumor to preserve a sufficient margin, and vascular replacement was concomitantly performed. Two patients underwent amputations for recurrent tumors because of extensive involvement of the limb by tumor. Adjuvant chemotherapy was administered in nine patients with large, high-grade tumors, adjuvant radiotherapy was performed in eight patients with tumors adjacent to critical organs, and both adjuvant chemotherapy and radiotherapy were performed in one patient postoperatively. The remaining 12 patients received only surgical treatment. Additional local recurrences were diagnosed by routine surveillance every 3 months after surgery. Informed consent was obtained from all participants. The institutional review board of Aichi Cancer Center approved this study.
Statistical Analysis
Overall survival rates, local rerecurrence-free rates, factors associated with survival and local rerecurrence-free rates, and amputation rates were examined. Kaplan-Meier analysis was used to determine survival rate, local rerecurrencefree rates, and amputation rates with time zero defined as the date of operation and censored at the date of last followup or death, local recurrence, and amputation, respectively. Factors associated with survival rates and local rerecurrence-free rates included age (male versus female), sex (< 60 years versus $ 60 years), tumor size (< 10 cm versus $ 10 cm), grade (low versus high), depth (superficial versus deep), location (lower extremity versus upper extremity, trunk), histology (infiltrative tumor versus noninfiltrative tumor), surgical margin (negative versus positive), adjuvant radiation (with or without), adjuvant chemotherapy (with versus without), and time from previous surgery to recurrence (< 2 years versus $ 2 years); the log-rank test was used to compare survival times between groups (Tables 2, 3 ). Probability values < 0.05 were considered significant. Statistical analysis was performed using SPSS 23.0 software (IBM Corp, New York, NY, USA).
Results
Overall 5-and 10-year survival rates were 70% (95% confidence interval [CI], 50%-91%) and 44% (95% CI, 12%-76%), respectively (Fig. 1A) , and 12 patients (40%) had developed distant metastases after a second resection. Ten patients (33%) had additional local recurrences, and overall 5-and 10-year local rerecurrence-free rates were 66% (95% CI, 48%-85%) and 50% (95% CI, 18%-81%), respectively (Fig. 1B) . Further recurrences occurred in three of the eight patients (38%) with liposarcomas, two of the seven patients (29%) with undifferentiated pleomorphic sarcomas, two of the four patients (50%) with myxofibrosarcomas, two of the four patients (50%) with leiomyosarcomas, and one of the seven patients (14%) with other types of tumors. At followup, 15 patients showed no signs of their soft tissue sarcoma, six were living with tumor, and nine had died from their sarcoma. Positive margin was a risk factor associated with further recurrences (5-year local rerecurrence-free rates of positive margin: 20% [95% CI, 0%-52%], negative margin: 89% [95% CI, 74%-100%], p < 0.01) (Fig. 2 ) and with survival (5-year survival rates of positive margin: 36% [95% CI, 0%-75%], negative margin: 91% [95% CI, 74%-100%], p < 0.01) (Fig. 3) . Survival rate was lower in patients with recurrences developing within Depth could not be calculated as a result of the small number in the subcutaneous group; LRFSR = local recurrence-free survival rate; UPS = undifferentiated pleomorphic sarcoma; MFS = myxofibrosarcoma.
Volume 476, Number 9 Local Recurrence After Wide Resection 1795 2 years from the surgery relative to those who had recurrence after 2 years (5-year survival rates of within 2 years: 46% [95% CI, 2%-90%], after 2 years: 83% [95% CI, 62%-100%], p = 0.01) (Fig. 4) . With the numbers we had, we could not show that the use of adjuvants (chemotherapy or radiation) was associated with local rerecurrence or survival.
The proportion of patients who had an amputation was 17% (five patients) of 30 patients at final followup, and 5-and 10-year amputation-free rates after initial operation were 86% (95% CI, 74%-99%) and 81% (95% CI, 67%-96%), respectively (Fig. 5) . Two patients (7%) underwent amputation for local recurrent tumors after initial operation, and three patients (10%) underwent amputation for Depth could not be calculated as a result of the small number in the subcutaneous group; SR = survival rate; UPS = undifferentiated pleomorphic sarcoma; MFS = myxofibrosarcoma. further local recurrence as a result of extensive invasion by tumor.
Discussion
Treatment of locally recurrent tumors is challenging and complicated by prior treatment. Few studies have examined treatment strategies for local recurrence after previous surgery with wide margins [1, 11, 14, 21] . In treatment of recurrent tumors, it has been reported that positive margins are correlated to local recurrence, but the relationship between surgical margin and survival remains controversial [2, 10, 18, 24] , and risk factors for local recurrences after wide resection of soft tissue sarcomas have not been well established [1, 11, 21] . The present study aimed to examine oncologic outcomes of surgical treatment for patients with local recurrences after initial wide resection and to analyze factors associated with survival rates and local rerecurrencefree rates. We confirmed that surgical margin was a factor associated with local rerecurrence and survival, and survival was shown to decrease in patients with another recurrence occurring within 2 years from the time of surgery. Our study has some limitations. First, we used a retrospective design, so no concurrent controls were included for direct comparison. This would be difficult if not impossible to do, because we cannot accurately predict who will relapse and who will not, although a case-control study might more definitively support our findings. Second, the number of patients was relatively small for between-group analysis. We could not perform a multivariate analysis of local rerecurrence and survival because of low numbers of patients per explanatory variables. Third, we followed treatment guidelines for soft tissue sarcomas, but adjuvant treatments were not standardized. We selected adjuvant chemotherapy and radiotherapy according to histologic subtype, tumor size, or tumors adjacent to critical organs. Fig. 2 Kaplan-Meier curves show local rerecurrence-free survival by surgical margin. The 5-year local rerecurrence-free rates with a positive margin and negative margin were 20% (95% CI, 0%-52%) and 89% (95% CI, 74%-100%), respectively (log-rank test; p < 0.01). Fig. 3 Kaplan-Meier curves show overall survival by surgical margin. The 5-year overall survival rates with a positive margin and negative margin were 36% (95% CI, 0%-75%) and 91% (95% CI, 74%-100%), respectively (log-rank test; p < 0.01). Fig. 4 Kaplan-Meier curves show overall survival by time from initial operation to recurrence. The 5-year overall survival rates with rerecurrence within 2 years from initial operation and those for which rerecurrence was after 2 years were 46% (95% CI, 2%-90%) and 83% (95% CI, 62%-100%), respectively (logrank test; p = 0.01).
Fig. 5
Kaplan-Meier curves show amputation-free rates after initial operation. The 5-and 10-year amputation-free rates were 86% (95% CI, 74%-99%) and 81% (95% CI, 67%-96%), respectively.
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Local Recurrence After Wide ResectionSome selective biases existed in chemotherapy for patients with high-grade and large tumors and radiotherapy for patients with tumors adjacent to critical organs. Finally, there were various histologic subtypes with a relatively small number in each group to compare recurrence rates. However, surgical procedure was evaluated by MRI and CT and unchanged according to histologic subtype. A larger study will be needed to clarify the effects of tumor type on local rerecurrence. In the present study, 10 patients (33%) had additional local recurrences, and overall 5-and 10-year recurrencefree rates were 66% and 50%, respectively. The present study found overall 5-and 10-year survival rates of 70% and 44%, respectively ( Table 4) . Prognoses of patients with local recurrence after wide resection are poor, likely as a result of the inherently higher tumor aggressiveness although our study did not address that possibility [1, 11] . Rates of local recurrences for primary soft tissue sarcoma reportedly range from 7% to 15% and 5-year survival rates range from 70% to 90% with rerecurrence rates for patients with locally recurrent tumors and 5-year survival rates ranging from 27% to 47% and 52% to 76%, respectively [4, 8, 12, 13, 15, [17] [18] [19] 23] . For rerecurrence rates of surgical treatment for patients with local recurrence after wide resection, Abatzoglou et al. [1] reported that 24% of 25 patients had further local recurrences after wide resection including amputation, and Gronchi et al. [11] reported that 26% of patients treated with eradicating intent at a tumor center had further local recurrences (Table 4) . Amputation for recurrent soft tissue sarcomas is reportedly associated with improved local control of the disease [21] . This may result in a greater likelihood of local control than limbsparing procedures because nerves, vessel, muscle, and skin can be included. Rates of rerecurrence determined by the present study may be slightly high as a result of the low number of amputations performed relative to the numbers in previous reports [1, 11, 21] . They may also be affected by histologic type. Kikuta et al. [14] reported that rerecurrence after wide resection was observed in 60% of 30 patients with recurrent myxofibrosarcoma. In the present study, two (50%) of four patients with myxofibrosarcoma developed rerecurrences, indicating that a more careful surgical plan will be needed for infiltrative tumors such as myxofibrosarcoma. Gronchi et al. [11] found that the 5-year survival rate of patients treated at a tumor center was 50%, which was lower than that of patients previously treated elsewhere. Abatzoglou et al. [1] reported 1-and 5-year survival rates for 25 patients with further local recurrences after wide resection of 57% and 11%, respectively. We also did not address the potential benefits of perioperative radiotherapy, which has been shown in other studies to reduce local recurrence rates [1, 21] .
We found that positive margins were associated with further recurrence and poor prognosis. It is relatively well known that positive margins are correlated to local recurrence [18, 24] , but the relationship between surgical margin and survival remains controversial [2, 10] . In the present study, surgical margins may have shown a correlation with survival because other adjuvant treatments such as chemotherapy were not routinely used; only one-third of the patients received adjuvant therapy. With the numbers we had, we could not show that the use of adjuvants (chemotherapy or radiation) had an effect on local rerecurrence or survival, but our study is not designed to assess that. Newer therapies (such as the molecule target drug that includes tyrosine kinase inhibitors) were only used in relatively few of our patients. We also confirmed that time from primary surgery to recurrence was a factor associated with survival. Approximately two-thirds of patients reportedly have recurrences within 2 years after the primary surgery, and Eilber et al. [4] reported that the prognoses for patients who developed local recurrences in < 16 months were poorer than that for patients whose local recurrence developed after 16 months. The present study's findings also suggest that patient prognosis is poor for those with recurrences within 2 years of the primary surgery. These findings support the contention that local recurrence is an indicator of an aggressive tumor when it develops even after wide resection with an eradicating intent within a specialized team [11] . Although our study did not adequately assess this, we believe that for patients whose tumors recur within 2 years of the primary surgery, adjuvant chemotherapy including new agents such as molecule target drugs should be considered and discussed with the treating team and the patient because these patients seem to have a particularly poor prognosis, possibly as a result of tumor aggressiveness. In our study, the proportion of patients who had an amputation was 17% at final followup, and 5-and 10-year amputation-free rates after initial surgery were 86% and 81%, respectively. Amputation rates during surgical resection are reportedly higher for local recurrent tumors than primary tumors [4, 24] . Eilber et al. [5] found that 2% of patients with primary tumors were treated by amputation; this rate increased to 11% with recurrent tumors. Trovik et al. [24] similarly reported amputation rates of 9% for primary tumors and 22% for recurrent tumors. Abatzoglou et al. [1] reported an amputation rate of 16% for local recurrence after initial multidisciplinary management. Stojadinovic et al. [21] reported that amputations were performed in 9% of patients with local recurrences after wide resection. Limb salvaging in patients with local recurrences may be more difficult to manage than that in patients with primary tumors as a result of prior treatment. In patients with local recurrences after wide resection, amputation may be one alternative that may help to prevent further recurrences as a result of the difficulty of limb salvaging.
In conclusion, a positive margin was a risk factor of further recurrence and poor prognosis in patients with local recurrences after wide resection of soft tissue sarcomas. A surgical procedure with negative margins appears to be important for reducing the likelihood of local recurrences after wide resection of soft tissue sarcomas. Our findings also suggest that when tumor recurrence is evident within 2 years from the primary surgery, local recurrence is associated with poorer prognosis, and local recurrence after wide resection may be an indicator of aggressive tumor biology, although further studies are needed to confirm these observations.
